Stock Events

Stock Events

Atara Biotherapeutics (AT20.F) Q1 2026 Earnings

16MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.77

-0.14

1.5

3.13

Details

Expected EPS

-0.152989025

Actual EPS

-0.2174375

Surprise EPS

-0.06

Surprise Percent

+42.13%

Description

Atara Biotherapeutics (AT20.F) has reported earnings of -0.2174375 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.